Trial

NCT03393117

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Case Comprehensive Cancer Center
Collaborators
Condition
Breast Cancer
Intervention
Liposomal Bupivacaine
Why stopped
No accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-22